| P2093 | author name string | Bingbing X Li | |
| | Xiangshu Xiao | |
| | Kinrin Yamanaka | |
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| | Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions | Q27748755 |
| | A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 |
| | WAF1, a potential mediator of p53 tumor suppression | Q27861121 |
| | Transcriptional regulation by the phosphorylation-dependent factor CREB | Q28210623 |
| | A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V | Q28294206 |
| | Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase | Q28302692 |
| | Induction of apoptosis in fibroblasts by c-myc protein | Q29614346 |
| | The Bcl2 family: regulators of the cellular life-or-death switch | Q29614982 |
| | CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals | Q29620470 |
| | Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines | Q30617388 |
| | Identification of small-molecule antagonists that inhibit an activator: coactivator interaction | Q31134749 |
| | Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase | Q31440469 |
| | CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy | Q33904846 |
| | Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues | Q33934262 |
| | Targeting CREB for cancer therapy: friend or foe | Q34387213 |
| | CREB: the unindicted cancer co-conspirator | Q34440831 |
| | Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism | Q34467554 |
| | Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer | Q34684234 |
| | Transcription factors as targets for cancer therapy | Q34932264 |
| | Aminophospholipid asymmetry: A matter of life and death | Q35019755 |
| | Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. | Q35512047 |
| | Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis | Q36562739 |
| | Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth | Q38329699 |
| | A pivotal role of cyclic AMP-responsive element binding protein in tumor progression | Q38344626 |
| | Design, synthesis, and biological evaluation of conformationally constrained analogues of naphthol AS-E as inhibitors of CREB-mediated gene transcription | Q39372398 |
| | Discovery of a small-molecule inhibitor of the KIX-KID interaction | Q39790454 |
| | miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia | Q39877560 |
| | New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). | Q40359521 |
| | The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia | Q40433742 |
| | Chemical substituent effect on pyridine permeability and mechanistic insight from computational molecular descriptors. | Q42131000 |
| | Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL. | Q42278494 |
| | Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia | Q44588094 |
| | Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor | Q44778899 |
| | A new class of macrocyclic receptors from iota-peptides | Q46343075 |
| | t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism | Q46805127 |
| | Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells | Q73873977 |
| | cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis | Q79801048 |
| | Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis | Q81040998 |
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6811-6820 | |
| P577 | publication date | 2012-10-04 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | Structure-activity relationship studies of naphthol AS-E and its derivatives as anticancer agents by inhibiting CREB-mediated gene transcription | |
| P478 | volume | 20 | |